Jim Cramer - Mad Money BioMarin Pharmaceutical BMRN-Q DON'T BUY Jun 11, 2025

The orphan drug model no longer works.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$57.130

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

David Burrows

Barometer Capital Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Kim Bolton

Black Swan Dexteritas

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money BioMarin Pharmaceutical BMRN-Q DON'T BUY Jun 11, 2025

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals